Speaking recently to a BrightFocus Chat audience, a leading vision scientist expressed hope for potential treatments for geographic atrophy (GA), one of the major causes of vision loss from age-related macular degeneration (AMD).
Working to save sight, BrightFocus’ National Glaucoma Research program is supporting Kathryn Burdon, PhD, of Australia’s University of Tazmania and Girum Gessesse, MD, of Ethiopia’s St. Paul’s Hospital Millennium Medical College to expand our scientific understanding of glaucoma in Africa.
Sarah Doyle, PhD, and Matthew Campbell, PhD, have spent much of their married life doing research together. In this interview (reposted from 2016), they talk about how their partnership began, what continues to drive them, and surprising turns their work has taken on the path to curing diseases of mind and sight.
For a long time we’ve known that hypertension in midlife increases the risk of Alzheimer’s. Now BrightFocus-funded research is exploring that connection – with some surprising results that are relevant to COVID-19.
Longtime friend and ARVO President Dan Stamer, PhD, tells us about his EyeFind initiative, alternative plans for this year’s annual meeting, how research is a team sport, and why he and other scientists are desperate to get back to the lab.
April 28, 2020
Donate to Cure Brain and Eye Diseases
Help end Alzheimer's, Macular Degeneration, and Glaucoma